Evidence map›Paper›PMID 36160802›Full record

ArticleFrontiers in pediatrics2022

Case report: Microcirculatory leukocytes in a pediatric patient with severe SARS-CoV-2 pneumonia. Findings of leukocytes trafficking beyond the lungs.

Gabriella Bottari, Can Ince, Valerio Confalone, Salvatore Perdichizzi, Chiara Casamento Tumeo, Joseph Nunziata, Stefania Bernardi, Francesca Calò Carducci, Laura Lancella, Paola Bernaschi and 4 more

Abstract readCase Reports
In one paragraph

Article in Frontiers in pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Gabriella BottariPediatric Intensive Care Unit, Department of Emergency and General Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Can InceDepartment of Intensive Care, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Valerio ConfalonePediatric Intensive Care Unit, Department of Emergency and General Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Salvatore PerdichizziPediatric Intensive Care Unit, Department of Emergency and General Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Chiara Casamento TumeoDepartment of Pediatrics, Residency School of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, University of Rome Tor Vergata, Rome, Italy.
Joseph NunziataPediatric Intensive Care Unit, Department of Emergency and General Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Stefania BernardiInfectious Diseases and Immuno-Infectiology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Francesca Calò CarducciInfectious Diseases and Immuno-Infectiology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Laura LancellaInfectious Diseases and Immuno-Infectiology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Paola BernaschiUnit of Microbiology and Diagnostic Immunology, Department of Diagnostic and Laboratory Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Cristina RussoVirology and Mycobacteria Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Carlo Federico PernoMultimodal Medicine Research Area, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Corrado CecchettiPediatric Intensive Care Unit, Department of Emergency and General Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Alberto VillaniGeneral Pediatric and Infectious Disease Unit, Department of Emergency and General Pediatrics, Bambino Gesù Children's Hospital, IRCSS, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: SARS-CoV-2 can lead to excessive coagulation and thrombo-inflammation with deposition of microthrombi and microvascular dysfunction. Several studies in human and animal models have already evidenced biomarkers of endothelial injury during SARS-CoV-2 infection. Real-time observation of sublingual microcirculation using an handheld vital microscopy with an Incident Dark Field (IDF) technique could represent a non-invasive way to assess early signs of microvascular dysfunction and endothelial inflammation in patients with severe COVID-19 infection. Clinical case: We report for the first time in a pediatric patient with severe SARS-CoV-2 pneumonia findings about microcirculatory leukocytes in the sublingual microcirculation of a 7 month-old patient admitted to our PICU using handheld vital microscopy with IDF technique. Results: Sublingual microcirculation analysis revealed the presence of microcirculatory alterations and an extensive presence of leukocytes in the patient's sublingual microcirculation. It's significant to underline how the patient didn't show a contextual significant increase in inflammatory biomarkers or other clinical signs related to an inflammatory response, beyond the presence of severe hypoxic respiratory failure. Conclusion: Leukocyte activation in multiple organs can occur at the endothelial lining of the microvasculature where a surge of pro-inflammatory mediators can result in accumulation of activated leukocytes and degradation of the endothelium. The introduction of a method to assess in a non-invasive, real-time manner the extent of inflammation in a patient with COVID19 could lead to potential clinical and therapeutic implications. However, more studies are required to prove that studying leukocytes microcirculation using sublingual microcirculation analysis could be useful as a bedside point of care monitor to predict the presence of systemic inflammation associated with the impact of COVID-19, leading in a late phase of severe SARS-CoV-2 infection to a microvascular dysfunction and micro-thrombosis.

Indexed as

inflammationmicrocirculationmicro-thrombosispediatric critical carerolling leukocytesSARS-CoV-2

Identifiers

PMID36160802
PMCPMC9493019

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.